Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 1
2020 3
2022 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA.
Yaung SJ, Woestmann C, Ju C, Ma XM, Gattam S, Zhou Y, Xi L, Pal S, Balasubramanyam A, Tikoo N, Heussel CP, Thomas M, Kriegsmann M, Meister M, Schneider MA, Herth FJ, Wehnl B, Diehn M, Alizadeh AA, Palma JF, Muley T. Yaung SJ, et al. Among authors: tikoo n. Cancers (Basel). 2022 May 18;14(10):2479. doi: 10.3390/cancers14102479. Cancers (Basel). 2022. PMID: 35626082 Free PMC article.
Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer.
Max Ma X, Bendell JC, Hurwitz HI, Ju C, Lee JJ, Lovejoy A, Mancao C, Nicholas A, Price R, Sommer N, Tikoo N, Yao L, Yaung SJ, Palma JF. Max Ma X, et al. Among authors: tikoo n. Clin Cancer Res. 2020 Aug 1;26(15):4010-4017. doi: 10.1158/1078-0432.CCR-19-1209. Epub 2020 Mar 27. Clin Cancer Res. 2020. PMID: 32220893 Clinical Trial.
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I-IV Non-Small Cell Lung Cancer.
Jiang J, Adams HP, Yao L, Yaung S, Lal P, Balasubramanyam A, Fuhlbrück F, Tikoo N, Lovejoy AF, Froehler S, Fang LT, Achenbach HJ, Floegel R, Krügel R, Palma JF. Jiang J, et al. Among authors: tikoo n. J Mol Diagn. 2020 Feb;22(2):228-235. doi: 10.1016/j.jmoldx.2019.10.013. Epub 2019 Dec 16. J Mol Diagn. 2020. PMID: 31837429 Free article.
Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer.
Jiang J, Adams HP, Lange M, Siemann S, Feldkamp M, McNamara S, Froehler S, Yaung SJ, Yao L, Balasubramanyam A, Tikoo N, Ju C, Achenbach HJ, Krügel R, Palma JF. Jiang J, et al. Among authors: tikoo n. BMC Cancer. 2020 Sep 15;20(1):885. doi: 10.1186/s12885-020-07340-z. BMC Cancer. 2020. PMID: 32933495 Free PMC article.